We’re starting off the day with a breakdown of the biggest pre-market stock movers for Thursday morning!
Moving stocks this morning are earnings reports, acquisition rumors, clinical trial data, and more.
Let’s get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Capri (NYSE:CPRI) stock is rocketing more than 56% on reports its being by Tapestry (NYSE:TPR).
- PHAXIAM Therapeutics (NASDAQ:PHXM) shares are soaring over 37% alongside heavy pre-market trading.
- AppLovin (NASDAQ:APP) stock is surging more than 24% after .
- Ebet (NASDAQ:EBET) shares are rising over 22% as it continues a recent rally.
- Vistagen Therapeutics (NASDAQ:VTGN) stock is gaining more than 20% alongside .
- MDxHealth (NASDAQ:MDXH) shares are increasing over 15% after getting .
- Avalo Therapeutics (NASDAQ:AVTX) stock is climbing more than 14% with heavy early morning trading.
- Genprex (NASDAQ:GNPX) shares are heading over 12% higher on Thursday morning.
- T2 Biosystems (NASDAQ:TTOO) stock is jumping more than 11% as it .
- Motorsport Games (NASDAQ:MSGM) shares are up close to 11% on Thursday morning.
10 Top Losers
- Galera Therapeutics (NASDAQ:GRTX) stock is crashing over 81% after the Food and Drug Administration .
- Amyris (NASDAQ:AMRS) shares are plummeting more than 61% after .
- Origin Mat (NASDAQ:ORGN) stock is diving over 54% after releasing its .
- SciSparc (NASDAQ:SPRC) shares are tumbling more than 39% after announcing a .
- Organogenesis (NASDAQ:ORGO) stock is taking an over 32% beating after .
- Wolverine World Wide (NYSE:WWW) shares are falling more than 28% with the release of its .
- Mogo (NASDAQ:MOGO) stock is dropping over 27% ahead of its earnings release later today.
- Matinas BioPharma (NYSEMKT:MTNB) shares are sliding more than 23% after .
- 180 Life Sciences (NASDAQ:ATNF) stock is slipping 23% following a rally yesterday.
- Renovaro Biosciences (NASDAQ:RENB) shares close out our pre-market stock movers down over 20% .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
